ANSON RESOURCES WKN: A2AC6W ISIN: AU000000ASN8 Kürzel: 9MY Forum: Aktien Thema: Hauptdiskussion
The lithium carbonate samples were created at the company’s Lithium Innovation Centre in Florida, USA, using equipment that replicates the DLE process planned for the proposed production plant at the project site. Over the past month, Anson has produced 33 gallons of eluate from 99 gallons of raw brine sourced from Paradox’s Long Canyon Unit 2 well. The company plans to ramp up production in the coming month and thereafter, relocate the sample demonstration plant to the proposed production site at the project. This will ensure a continuous production of samples to meet expected demand from potential original equipment manufacturer (OEM) partners, including electric vehicle and lithium-ion battery manufacturers. The DLE, the first step in the lithium carbonate production process, has been rigorously tested and validated at an independent laboratory in Salt Lake City.
|
|
Thema | ||
|---|---|---|---|
| 1 | DAX Prognose / Germany 40 | -0,86 % | |
| 2 | Security der nächsten Generation | -0,59 % | |
| 3 | MICRON TECHNOLOGY Hauptdiskussion | +4,49 % | |
| 4 | RENK (für normale, sachliche Kommunikation!) | -6,41 % | |
| 5 | Novo Nordisk nach Split | +2,43 % | |
| 6 | Iris Energy | -5,80 % | |
| 7 | SHOP APOTHEKE EUROPE INH. Hauptdiskussion | +9,36 % | |
| 8 | DAX / Germany 40 Hauptdiskussion | -0,86 % | |
| 9 | ALMONTY TO THE MOON | -7,17 % | |
| 10 | APLD - 2024 | -5,18 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Security der nächsten Generation | -0,59 % | |
| 2 | MICRON TECHNOLOGY Hauptdiskussion | +4,49 % | |
| 3 | RENK (für normale, sachliche Kommunikation!) | -6,41 % | |
| 4 | Novo Nordisk nach Split | +2,43 % | |
| 5 | Iris Energy | -5,80 % | |
| 6 | SHOP APOTHEKE EUROPE INH. Hauptdiskussion | +9,36 % | |
| 7 | ALMONTY TO THE MOON | -7,17 % | |
| 8 | PLUG POWER Hauptdiskussion | -3,81 % | |
| 9 | Mercedes-Benz Group Hauptdiskussion | -1,57 % | |
| 10 | HauptForum SK HYNIC | -1,73 % | Alle Diskussionen |